Compare stocks

The Goldman Sachs Group, Inc. (GS) vs Morgan Stanley (MS)

GS is cheaper with stronger earnings momentum; MS leads on growth, momentum and balance-sheet metrics

Goldman Sachs leads Qanvo's scorecard on valuation (75 vs 25), profitability and quality (67 vs 33) and earnings momentum (100 vs 0), with a forward P/E of 11.81× versus 13.41× for Morgan Stanley. Morgan Stanley leads on growth (75 vs 25), technical momentum (80 vs 20), financial resilience (100 vs 0) and lower risk (75 vs 25), with last-year revenue growth of 15.75% versus -2.93% for GS. Both are mega-cap capital-markets financials that fell about 14% over three months and trade below their 200-day averages after recent death crosses. Leverage, free cash flow and enterprise value ratios do not compare cleanly with non-financial companies. The trade-off is a cheaper, higher-margin but more volatile and more Global Markets-concentrated GS versus a pricier, more diversified and calmer MS.

Business overview

Both are US-listed, mega-cap financial firms in Financials, Financial - Capital Markets. Morgan Stanley is larger by market cap at $284.10B versus $259.83B for Goldman Sachs. Per their profiles, Goldman Sachs operates four divisions: Investment Banking, Global Markets, Asset Management, and Consumer & Wealth Management. Morgan Stanley operates three: Institutional Securities, Wealth Management, and Investment Management. The mix differs. In fiscal 2025, Global Markets made up 71.12% of Goldman's segment revenue and Investment Management 28.62%. Morgan Stanley's was split more evenly, with Institutional Securities at 46.36% and Wealth Management at 44.50%. Geographically, the Americas supplied 62.71% of Goldman's revenue versus 74.88% for Morgan Stanley, and Goldman has the larger EMEA share (24.29% versus 11.79%). Morgan Stanley has 83,000 employees against 47,500 at Goldman. Because both are capital-markets-oriented financials, ratios such as debt/equity, free cash flow and enterprise value do not compare cleanly with non-financial companies.

  • Morgan Stanley's market cap of $284.10B is above Goldman Sachs' $259.83B.
  • Global Markets is 71.12% of Goldman's segment revenue, while Morgan Stanley's largest segment, Institutional Securities, is 46.36%.
  • Americas revenue is 74.88% of Morgan Stanley's total versus 62.71% for Goldman Sachs.
  • Morgan Stanley's Wealth Management is 44.50% of revenue; Goldman's profile lists Consumer & Wealth Management but the segment data does not break it out.

Valuation

Qanvo's scorecard gives Goldman Sachs the valuation lead (75 versus 25), meaning it is the cheaper of the two on the metrics used. Goldman trades at a trailing P/E of 11.72× and a forward P/E of 11.81× (based on analyst estimates), versus 13.84× and 13.41× for Morgan Stanley. Price/sales is 2.10× versus 2.19×, and PEG is 2.62× versus 1.92×, where Morgan Stanley is lower. EV/EBITDA and free-cash-flow yield are not usable here: both companies report negative free cash flow, and enterprise value is not meaningful for banks, so treat them as N/M. Against its own 5-year range, Goldman's trailing P/E of 11.72× sits below its median of 14.66× (range 5.03× to 19.84×). Morgan Stanley's 13.84× is also below its median of 15.68× (range 9.68× to 21.07×). Versus sector peers, Goldman's trailing P/E is at the 39th percentile (sector median 13.03×) and Morgan Stanley's at the 55th. Morgan Stanley's premium sits alongside faster reported revenue growth and a calmer risk profile, while Goldman's discount coincides with higher operating margin and ROE on the quality rank, but a lower growth score and higher debt/equity. A lower multiple therefore does not simply mean better value.

  • Trailing P/E is 11.72× for Goldman Sachs versus 13.84× for Morgan Stanley.
  • Forward P/E (estimate-based) is 11.81× versus 13.41×, against an industry median of 11.88×.
  • PEG favours Morgan Stanley at 1.92× versus 2.62×, despite its higher P/E.
  • Both trade below their own 5-year median P/E: 14.66× for Goldman, 15.68× for Morgan Stanley.

Growth

Morgan Stanley leads the growth scorecard (75 versus 25). Reported revenue growth over the last year is 15.75% for Morgan Stanley versus -2.93% for Goldman Sachs, though Goldman's latest quarter was stronger at 17.25% versus 10.74%. Three-year revenue CAGR is close: 22.55% for Morgan Stanley and 22.11% for Goldman. On EPS, Goldman grew 41.14% over the last year and 38.86% in the latest quarter, versus 28.31% and 8.21% for Morgan Stanley; three-year EPS CAGR is 19.52% versus 18.37%. The trajectory is uneven for Goldman: annual revenue went from $108.42B in 2023 to $126.85B in 2024 and $125.10B in 2025, while its quarterly revenue swung from $17.23B in Q1 FY2026 to $38.43B in Q2. Morgan Stanley's annual revenue rose each year, from $88.29B to $103.14B to $114.98B, and its quarterly revenue has been steadier, though EPS slipped from $3.41 to $3.03 over the last two quarters. Analyst estimates, not reported results, point to slower growth: expected EPS growth next fiscal year is 4.51% for Goldman versus 6.98% for Morgan Stanley. FY1 consensus EPS is 71.44 versus 12.90, rising to 74.66 versus 13.80 for FY2.

  • Last-year revenue growth is 15.75% for Morgan Stanley versus -2.93% for Goldman Sachs.
  • Last-year EPS growth favours Goldman at 41.14% versus 28.31%.
  • Three-year revenue CAGR is nearly level at 22.55% versus 22.11%.
  • Analyst-estimated next-year EPS growth is 6.98% for Morgan Stanley versus 4.51% for Goldman.

Profitability, cash flow & financial health

Qanvo's scorecard gives GS the lead on profitability and quality (67 vs 33 for MS, relative ranks within this pair). GS has the higher operating margin at 25.00% versus 20.54%, and the higher net margin at 17.95% versus 15.82%. Return on equity is nearly level: 18.08% for MS and 17.81% for GS, so GS's lead rests on margins. GS's operating margin also rose 8.29% over the past year against 1.71% for MS. Financial resilience goes to MS (100 vs 0). Debt to equity is 4.52× for MS and 6.71× for GS, and interest coverage is 0.53× versus 0.44×. For banks and brokers these ratios are shaped by funding and trading balance sheets, so they do not compare with industrial companies, and the interest coverage figures are not a standard solvency signal here. Both report negative trailing free cash flow, $-39.98B at GS and $-58.61B at MS, which is typical of trading-driven balance sheets and is not a clean quality measure. Piotroski F-score is 6 for MS and 5 for GS. Net debt/EBITDA, gross margin comparisons and ROIC are not usable here.

  • GS's operating margin is 25.00% versus 20.54% for MS.
  • ROE is close: MS 18.08% against GS 17.81%.
  • MS carries less leverage, with debt to equity of 4.52× versus 6.71× for GS.
  • Trailing free cash flow is negative at both: GS $-39.98B and MS $-58.61B.

Shareholder returns & capital allocation

MS offers the higher dividend yield at 2.34% versus 2.05% for GS, but also the higher payout ratio at 34.37% versus 25.88%, so GS retains more of its earnings. GS has grown its dividend faster, at 15.87% over three years versus 9.28% for MS, and has done so for 14 years versus 12. GS's latest declared quarterly dividend is 5 per share, with an ex-dividend date of Dec 2, 2026; MS's latest was 1.15 per share, ex-dividend Oct 30, 2026. GS has shrunk its share count faster: the one-year change is -4.41% versus -1.69% for MS, which points to heavier buybacks relative to its size. GS repurchased $12.36B of stock in fiscal 2025 against $5.83B for MS, while dividends paid were $5.28B versus $6.59B. MS therefore directs more cash to dividends and GS more to buybacks. The scorecard has no capital allocation category, so there is no clear leader here, and the facts give no stated capital return targets for either firm.

  • MS yields 2.34% versus 2.05% for GS.
  • GS's payout ratio is 25.88% against 34.37% for MS.
  • GS's one-year share count change is -4.41% versus -1.69% for MS.
  • GS repurchased $12.36B of stock in fiscal 2025 versus $5.83B for MS.

Earnings intelligence

Over the last four reported quarters GS beat EPS consensus every time, by 32.27% (Oct 13, 2026), 44.29%, 6.56% and 19.74%. MS also beat each time, by 3.41% (Oct 14, 2026), 18.09%, 13.58% and 10.29%. GS's latest EPS surprise is roughly ten times MS's, and its revenue surprise of 10.97% compares with 2.06% for MS. The scorecard gives GS the earnings momentum lead (100 versus 0), with a beat streak of 13 against 11. The stock reactions were mixed. After the latest report GS moved -1.70% and MS -2.43%. In the prior quarter GS rose 10.15% while MS fell 4.08%. In the two earlier quarters GS gained 0.20% and 3.14%, and MS gained 2.17% and 4.60%. Analysts' 30-day EPS revision is 3.44% for GS and 0.41% for MS, so estimates are rising faster for GS (these are estimates, not reported results). The next report is estimated, not confirmed: GS on Jan 19, 2027 and MS on Jan 14, 2027. No guidance appears in the facts. The latest report strengthened GS's relative earnings case more than MS's.

  • GS's latest EPS surprise of 32.27% compares with 3.41% for MS.
  • GS's latest revenue surprise of 10.97% compares with 2.06% for MS.
  • The 30-day EPS revision is 3.44% for GS versus 0.41% for MS.
  • Both reacted negatively to the latest report: GS -1.70%, MS -2.43%.

Technicals, relative performance & risk

MS leads the technical momentum scorecard (80 versus 20 for GS). By price return, MS is ahead over 1 month (2.8% vs 0.2%), 3 months (-15.9% vs -16.5%), 6 months (-4.8% vs -7.3%) and 1 year (15.1% vs 13.1%). GS leads over 3 years (158.5% vs 130.3%) and 5 years (124.1% vs 87.9%). Total returns follow the same order, for example 1-year 17.0% for MS and 15.4% for GS. Both trade below their averages. GS is -2.63% from its 20-day, -4.18% from its 50-day and -8.13% from its 200-day average; MS is -1.57%, -4.12% and -5.65%. Both show a death cross (GS Oct 26, 2026; MS Nov 10, 2026). RSI(14) is 43.33 for GS and 44.57 for MS. GS is 23.96% below its 52-week high, MS 20.98%. Relative strength rating is 47 for GS and 54 for MS. MS is calmer: 1-year beta 1.45 vs 1.66, 30-day historical volatility 34.54% vs 34.49% (essentially level), and 1-year drawdown -21.91% vs -24.85%. Technicals favour MS while valuation and earnings momentum favour GS, so the signals conflict.

  • MS's 6-month price return of -4.8% is ahead of GS's -7.3%.
  • GS's 5-year price return of 124.1% exceeds MS's 87.9%.
  • GS sits 8.13% below its 200-day average versus 5.65% for MS.
  • GS's 1-year beta of 1.66 compares with 1.45 for MS.

Analyst & ownership sentiment

Analyst opinions are split and the two sources in the facts do not fully agree. GS carries a mean rating score of 2.5, labelled Buy, from 18 analysts, while the broader consensus tally labels it Hold (23 Buy, 29 Hold, 3 Sell). MS has a rating score of 2.75, labelled Hold, yet its tally is labelled Buy (29 Buy, 23 Hold, 1 Sell). These are analysts' opinions, not facts about future results. Mean targets imply 18.74% upside for GS (1,042.00) and 15.88% for MS (212.67). Over 30 days, estimate revisions were 3.44% for GS EPS versus 0.41% for MS, and GS had one upgrade with no downgrades. Institutions hold 72.50% of GS and 86.48% of MS, with 3-month changes of 1.96% and 2.00%; these filings lag by weeks. Insiders did not buy at either. GS had 10 sells in 90 days (net -12.0M), mostly tax withholding in the trade list, while MS had 1 sell (net -454.3K), and Mitsubishi UFJ, a 10 percent owner, recorded dispositions. Short interest is 2.13% of float at GS (down 8.96%) and 0.99% at MS (up 7.49%).

  • GS mean target implies 18.74% upside versus 15.88% for MS, both analysts' estimates.
  • GS 30-day EPS estimate revision is 3.44% against 0.41% for MS.
  • Institutional ownership is 72.50% at GS versus 86.48% at MS, with similar 3-month increases of 1.96% and 2.00%.
  • Short interest is 2.13% of float at GS versus 0.99% at MS, with GS falling 8.96% and MS rising 7.49%.

Risks & catalysts

Both are capital-markets-focused financials, so earnings depend on deal and trading activity, and both have fallen about 14% over three months (GS -14.11%, MS -14.33%). Both trade below their 200-day averages after recent death crosses (GS Oct 26, 2026; MS Nov 10, 2026). Leverage ratios are high for both and are not comparable to non-financial companies; GS debt-to-equity is 6.71× versus 4.52× for MS, and Qanvo's resilience scorecard favours MS. Volatility is similar, with 30-day historical volatility of 34.49% for GS and 34.54% for MS, though GS has the higher 1-year beta (1.66 versus 1.45) and deeper 1-year drawdown (-24.85% versus -21.91%). GS revenue fell 2.93% year over year and GS's next-year EPS growth estimate is 4.51%, versus 6.98% for MS, so both lean on estimates. GS is more concentrated in Global Markets (71.12% of 2025 revenue). MS's largest segments are Institutional Securities (46.36%) and Wealth Management (44.50%). Catalysts: GS reports Jan 19, 2027 and MS Jan 14, 2027, neither confirmed. GS goes ex-dividend Dec 2, 2026 ($5 per share); no upcoming MS ex-date is listed.

  • GS debt-to-equity is 6.71× versus 4.52× for MS, a ratio that is not comparable with non-financial firms.
  • GS 1-year beta is 1.66 versus 1.45 for MS.
  • GS gets 71.12% of revenue from Global Markets versus 46.36% for MS's largest segment, Institutional Securities.
  • Unconfirmed earnings are due Jan 14, 2027 for MS and Jan 19, 2027 for GS.

Analysis written November 18, 2026. AI-generated, for information only; not investment advice.